Epsilon Healthcare Limited (AU:EPN)
ASX:EPN
Want to see AU:EPN full AI Analyst Report?
EPN Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.04
Previous CloseN/A
Volume222.34K
Average Volume (3M)0.00
Market Cap
AU$8.95M
Enterprise ValueAU$22.86M
Total Cash (Recent Filing)AU$242.86K
Total Debt (Recent Filing)AU$14.16M
Price to Earnings (P/E)―
Beta-0.30
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding389,104,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)4.19
Price to Sales (P/S)1.33
P/FCF Ratio-3.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue ReboundA ~53% revenue rebound in 2025 indicates improving market traction and demand for Epsilon's products. Sustained top-line growth provides a pathway to absorb fixed costs, improve operating leverage and support incremental investment in manufacturing and distribution over the next several quarters.
CGMP Manufacturing CapabilityOwning cGMP-compliant extraction and manufacturing facilities is a durable strategic asset for supplying regulated medicinal cannabis and pharma customers. It raises barriers to entry, supports quality/regulated-market access and underpins long-term contract and private-label manufacturing opportunities.
Diversified B2B Revenue StreamsPrivate-label manufacturing and distributor/healthcare partnerships spread revenue sources beyond direct product sales. This structural diversification reduces customer concentration risk, enables steady B2B demand and provides recurring contract opportunities that support revenue stability over months.
Bears Say
Persistent Negative Cash FlowOperating and free cash flow have been negative each year, reflecting ongoing cash burn. This structural cash deficit forces dependence on external financing, constrains reinvestment in growth and increases vulnerability to funding market conditions while margins remain negative.
Materially Increased LeverageDebt-to-equity of ~4.7x represents a material step-up in leverage versus prior years and coincides with shrinking equity. Elevated leverage limits financial flexibility, raises refinancing and covenant risk, and amplifies downside if revenue or margins weaken.
Sustained Unprofitable OperationsDespite revenue recovery, operating and net losses persist and net margins remain about -22%. Continued unprofitability undermines internal capital generation, delays self-sustaining growth and means the business must demonstrate durable margin improvement to achieve long-term financial stability.
Epsilon Healthcare Limited News
EPN FAQ
What was Epsilon Healthcare Limited’s price range in the past 12 months?
Epsilon Healthcare Limited lowest share price was AU$0.02 and its highest was AU$0.04 in the past 12 months.
What is Epsilon Healthcare Limited’s market cap?
Epsilon Healthcare Limited’s market cap is AU$8.95M.
When is Epsilon Healthcare Limited’s upcoming earnings report date?
Epsilon Healthcare Limited’s upcoming earnings report date is Sep 02, 2026 which is in 99 days.
How were Epsilon Healthcare Limited’s earnings last quarter?
Epsilon Healthcare Limited released its earnings results on Feb 27, 2026. The company reported AU$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.002.
Is Epsilon Healthcare Limited overvalued?
According to Wall Street analysts Epsilon Healthcare Limited’s price is currently Overvalued.
Does Epsilon Healthcare Limited pay dividends?
Epsilon Healthcare Limited does not currently pay dividends.
What is Epsilon Healthcare Limited’s EPS estimate?
Epsilon Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epsilon Healthcare Limited have?
Epsilon Healthcare Limited has 389,104,000 shares outstanding.
What happened to Epsilon Healthcare Limited’s price movement after its last earnings report?
Epsilon Healthcare Limited reported an EPS of AU$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Epsilon Healthcare Limited?
Currently, no hedge funds are holding shares in AU:EPN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Epsilon Healthcare Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
404.65%
Trailing 12-Months
Asset Growth
84.04%
Trailing 12-Months
Company Description
Epsilon Healthcare Limited
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.
Technical Analysis
Vita Life Sciences Limited
―
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―
Options Prices
Currently, No data available
---